These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 24188096)

  • 21. Operational feasibility of Plasmodium vivax radical cure with tafenoquine or primaquine following point-of-care, quantitative glucose-6-phosphate dehydrogenase testing in the Brazilian Amazon: a real-life retrospective analysis.
    Brito M; Rufatto R; Murta F; Sampaio V; Balieiro P; Baía-Silva D; Castro V; Alves B; Alencar A; Duparc S; Grewal Daumerie P; Borghini-Fuhrer I; Jambert E; Peterka C; Edilson Lima F; Carvalho Maia L; Lucena Cruz C; Maciele B; Vasconcelos M; Machado M; Augusto Figueira E; Alcirley Balieiro A; Menezes A; Ataídes R; Batista Pereira D; Lacerda M
    Lancet Glob Health; 2024 Mar; 12(3):e467-e477. PubMed ID: 38365417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vivax malaria in pregnancy and lactation: a long way to health equity.
    Brummaier T; Gilder ME; Gornsawun G; Chu CS; Bancone G; Pimanpanarak M; Chotivanich K; Nosten F; McGready R
    Malar J; 2020 Jan; 19(1):40. PubMed ID: 31969155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single Low Dose Primaquine (0.25 mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects.
    Bancone G; Chowwiwat N; Somsakchaicharoen R; Poodpanya L; Moo PK; Gornsawun G; Kajeechiwa L; Thwin MM; Rakthinthong S; Nosten S; Thinraow S; Nyo SN; Ling CL; Wiladphaingern J; Kiricharoen NL; Moore KA; White NJ; Nosten F
    PLoS One; 2016; 11(3):e0151898. PubMed ID: 27010542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primaquine-induced haemolysis in females heterozygous for G6PD deficiency.
    Chu CS; Bancone G; Nosten F; White NJ; Luzzatto L
    Malar J; 2018 Mar; 17(1):101. PubMed ID: 29499733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spatial distribution of G6PD deficiency variants across malaria-endemic regions.
    Howes RE; Dewi M; Piel FB; Monteiro WM; Battle KE; Messina JP; Sakuntabhai A; Satyagraha AW; Williams TN; Baird JK; Hay SI
    Malar J; 2013 Nov; 12():418. PubMed ID: 24228846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of hemolysis in Plasmodium vivax malaria patients receiving standard primaquine treatment in a population with high prevalence of G6PD deficiency.
    Liu H; Zeng W; Malla P; Wang C; Lakshmi S; Kim K; Menezes L; Yang Z; Cui L
    Infection; 2023 Feb; 51(1):213-222. PubMed ID: 35976559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rolling out the radical cure for vivax malaria in Asia: a qualitative study among policy makers and stakeholders.
    Adhikari B; Awab GR; von Seidlein L
    Malar J; 2021 Mar; 20(1):164. PubMed ID: 33757538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of G6PD Point-of-Care Tests among Healthy Volunteers in Yangon, Myanmar.
    Oo NN; Bancone G; Maw LZ; Chowwiwat N; Bansil P; Domingo GJ; Htun MM; Thant KZ; Htut Y; Nosten F
    PLoS One; 2016; 11(4):e0152304. PubMed ID: 27035821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness analysis of G6PD diagnostic test for Plasmodium vivax radical cure in Lao PDR: An economic modelling study.
    Aung YN; Tun STT; Vanisaveth V; Chindavongsa K; Kanya L
    PLoS One; 2022; 17(4):e0267193. PubMed ID: 35468145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malaria radical cure opportunity assessment in India: Discussing opportunities through stakeholder convening workshop and recommendation for improved access to malaria treatment.
    Tandon R; Spark-DePass E; Sharma A; Gerth-Guyette E; Slutsker L; Daumerie PG; Domingo GJ; Bird P; Agarwal N
    J Vector Borne Dis; 2020; 57(2):182-186. PubMed ID: 34290164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens.
    Chu CS; Bancone G; Moore KA; Win HH; Thitipanawan N; Po C; Chowwiwat N; Raksapraidee R; Wilairisak P; Phyo AP; Keereecharoen L; Proux S; Charunwatthana P; Nosten F; White NJ
    PLoS Med; 2017 Feb; 14(2):e1002224. PubMed ID: 28170391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Point-of-care G6PD diagnostics for Plasmodium vivax malaria is a clinical and public health urgency.
    Baird JK
    BMC Med; 2015 Dec; 13():296. PubMed ID: 26652887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. G6PD Deficiency and Antimalarial Efficacy for Uncomplicated Malaria in Bangladesh: A Prospective Observational Study.
    Ley B; Alam MS; Thriemer K; Hossain MS; Kibria MG; Auburn S; Poirot E; Price RN; Khan WA
    PLoS One; 2016; 11(4):e0154015. PubMed ID: 27128675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in Gia Lai Province, Vietnam.
    Võ TC; Lê HG; Kang JM; Nguyễn ĐTD; Nguyễn TH; Yoo WG; Goo YK; Thi Minh Trinh N; Van Khanh C; Hong Quang H; Na BK
    Parasitol Int; 2024 Jun; 100():102868. PubMed ID: 38387679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria.
    Satyagraha AW; Sadhewa A; Panggalo LV; Subekti D; Elyazar I; Soebianto S; Mahpud N; Harahap AR; Baird JK
    PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009610. PubMed ID: 34270547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.
    Bancone G; Gornsawun G; Chu CS; Porn P; Pal S; Bansil P; Domingo GJ; Nosten F
    PLoS One; 2018; 13(5):e0196716. PubMed ID: 29738562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.
    Baird JK; Battle KE; Howes RE
    Malar J; 2018 Jan; 17(1):42. PubMed ID: 29357870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primaquine for reducing Plasmodium falciparum transmission.
    Graves PM; Gelband H; Garner P
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008152. PubMed ID: 22972117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of G6PD deficiency and distribution of its genetic variants among malaria-suspected patients visiting Metehara health centre, Eastern Ethiopia.
    Shenkutie TT; Nega D; Hailu A; Kepple D; Witherspoon L; Lo E; Negash MT; Adamu A; Gebremichael SG; Gidey B; Tasew G; Feleke SM; Kebede T
    Malar J; 2022 Sep; 21(1):260. PubMed ID: 36076204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytochrome P450 2D6 (CYP2D6) and glucose-6-phosphate dehydrogenase (G6PD) genetic variations in Thai vivax malaria patients: Implications for 8-aminoquinoline radical cure.
    Chamchoy K; Sudsumrit S; Thita T; Krudsood S; Patrapuvich R; Boonyuen U
    PLoS Negl Trop Dis; 2022 Dec; 16(12):e0010986. PubMed ID: 36508454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.